Mesa Laboratories, Inc.
MLAB
$61.66
-$1.43-2.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.36% | 5.49% | 17.52% | 8.78% | 14.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.36% | 5.49% | 17.52% | 8.78% | 14.86% |
| Cost of Revenue | 12.22% | 12.33% | 15.02% | 4.12% | 3.50% |
| Gross Profit | -2.86% | 1.66% | 19.02% | 11.83% | 21.95% |
| SG&A Expenses | 7.27% | 13.31% | -0.87% | 0.50% | -0.38% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.01% | 11.47% | 6.58% | 1.21% | 0.98% |
| Operating Income | -51.81% | -67.20% | 8,725.37% | 6,703.33% | 1,057.53% |
| Income Before Tax | 79.56% | 100.17% | -213.93% | 387.70% | 516.76% |
| Income Tax Expenses | 339.07% | 136.51% | -218.24% | 504.21% | 233.25% |
| Earnings from Continuing Operations | 39.96% | 97.21% | -179.21% | 378.70% | 717.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 39.96% | 97.21% | -179.21% | 378.70% | 717.12% |
| EBIT | -51.81% | -67.20% | 8,725.37% | 6,703.33% | 1,057.53% |
| EBITDA | -23.70% | -16.77% | 25.54% | 24.81% | 58.27% |
| EPS Basic | 38.21% | 97.23% | -178.67% | 377.40% | 714.29% |
| Normalized Basic EPS | 285.53% | 6.43% | -213.17% | 420.49% | 290.83% |
| EPS Diluted | 37.10% | 97.23% | -179.49% | 373.91% | 706.65% |
| Normalized Diluted EPS | 281.26% | 6.43% | -213.22% | 417.05% | 289.91% |
| Average Basic Shares Outstanding | 1.26% | 0.83% | 0.67% | 0.48% | 0.47% |
| Average Diluted Shares Outstanding | 2.38% | 0.83% | 0.61% | 1.56% | 0.97% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.28% | -35.04% | -2.27% | 1.36% | 1.16% |